Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Sanchez

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Frontiers in Global Women'S Health|December 1, 2025
Assessing the impact of a business intelligence program on the employability and well-being of low-income women: a quasi-experimental study protocolMarco Faytong-Haro, Alonso Quijano-Ruiz, Daniel Sanchez-Pazmiño, et al.
International Journal of Molecular Sciences|January 11, 2022
Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing ProteinJinkal Modi, Abhishek Roy, Anjan K Pradhan, et al.
Cancers|January 28, 2026
Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test-An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System MalignanciesSakshi Khurana, Viriya Keo, Alexandra Larson, et al.
Frontiers in Oncology|February 15, 2021
Biological and Mechanical Synergies to Deal With Proton Therapy Pitfalls: Minibeams, FLASH, Arcs, and Gantryless RoomsAlejandro Mazal, Juan Antonio Vera Sanchez, Daniel Sanchez-Parcerisa, et al.
Molecular Therapy. Nucleic Acids|June 20, 2022
Serum microRNAs targeting <i>ACE2</i> and <i>RAB14</i> genes distinguish asymptomatic from critical COVID-19 patientsMaria Calderon-Dominguez, Eva Trejo-Gutierrez, Almudena González-Rovira, et al.
Molecular Biomedicine|April 10, 2026
Machine learning integrated clinical-proteomics data identifies a 6-protein panel signature for atherosclerotic severity and enhanced patient stratificationMª Jesús Extremera-García, Marta Rojas-Torres, Blanca Priego-Torres, et al.
Nature Communications|July 3, 2025
Variants in NR6A1 cause a novel oculo vertebral renal syndromeUma M Neelathi, Ehsan Ullah, Aman George, et al.
Science Advances|April 6, 2017
A novel artificial condensed matter lattice and a new platform for one-dimensional topological phasesIlya Belopolski, Su-Yang Xu, Nikesh Koirala, et al.
Research Square|November 28, 2024
Variants in <i>NR6A1</i> cause a novel oculo-vertebral-renal (OVR) syndromeUma M Neelathi, Ehsan Ullah, Aman George, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Variants in <i>NR6A1</i> cause a novel oculo-vertebral-renal (OVR) syndromeUma M Neelathi, Ehsan Ullah, Aman George, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Frontiers in Global Women'S Health|December 1, 2025
Assessing the impact of a business intelligence program on the employability and well-being of low-income women: a quasi-experimental study protocolMarco Faytong-Haro, Alonso Quijano-Ruiz, Daniel Sanchez-Pazmiño, et al.
International Journal of Molecular Sciences|January 11, 2022
Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing ProteinJinkal Modi, Abhishek Roy, Anjan K Pradhan, et al.
Cancers|January 28, 2026
Analytical Validation and Clinical Sensitivity of the Belay Summit™ 2.0 Cerebrospinal Fluid Liquid Biopsy Test-An Expanded Comprehensive Genomic Profiling Platform for Central Nervous System MalignanciesSakshi Khurana, Viriya Keo, Alexandra Larson, et al.
Frontiers in Oncology|February 15, 2021
Biological and Mechanical Synergies to Deal With Proton Therapy Pitfalls: Minibeams, FLASH, Arcs, and Gantryless RoomsAlejandro Mazal, Juan Antonio Vera Sanchez, Daniel Sanchez-Parcerisa, et al.
Molecular Therapy. Nucleic Acids|June 20, 2022
Serum microRNAs targeting <i>ACE2</i> and <i>RAB14</i> genes distinguish asymptomatic from critical COVID-19 patientsMaria Calderon-Dominguez, Eva Trejo-Gutierrez, Almudena González-Rovira, et al.
Molecular Biomedicine|April 10, 2026
Machine learning integrated clinical-proteomics data identifies a 6-protein panel signature for atherosclerotic severity and enhanced patient stratificationMª Jesús Extremera-García, Marta Rojas-Torres, Blanca Priego-Torres, et al.
Nature Communications|July 3, 2025
Variants in NR6A1 cause a novel oculo vertebral renal syndromeUma M Neelathi, Ehsan Ullah, Aman George, et al.
Science Advances|April 6, 2017
A novel artificial condensed matter lattice and a new platform for one-dimensional topological phasesIlya Belopolski, Su-Yang Xu, Nikesh Koirala, et al.
Research Square|November 28, 2024
Variants in <i>NR6A1</i> cause a novel oculo-vertebral-renal (OVR) syndromeUma M Neelathi, Ehsan Ullah, Aman George, et al.
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Variants in <i>NR6A1</i> cause a novel oculo-vertebral-renal (OVR) syndromeUma M Neelathi, Ehsan Ullah, Aman George, et al.
Pageof 20